Akso Health Group
AHG
$1.28
-$0.12-8.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.54% | 172.51% | 512.07% | 401.53% | 281.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.54% | 172.51% | 512.07% | 401.53% | 281.20% |
| Cost of Revenue | 79.65% | 184.14% | 556.98% | 436.87% | 301.67% |
| Gross Profit | -46.20% | -133.33% | -330.28% | -101.71% | 51.76% |
| SG&A Expenses | -30.41% | -45.85% | -58.43% | -57.40% | -56.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.36% | 45.48% | 69.20% | 14.80% | -17.56% |
| Operating Income | 29.77% | 43.60% | 54.58% | 56.86% | 58.06% |
| Income Before Tax | -2,445.93% | -2,029.55% | -1,728.80% | -543.58% | 63.03% |
| Income Tax Expenses | -79,128.06% | -96,330.53% | -123,304.00% | -55,426.98% | 28.10% |
| Earnings from Continuing Operations | -1,962.03% | -1,627.98% | -1,385.93% | -427.94% | 62.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.05% | -100.05% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2,139.02% | 1,165.29% | 750.87% | 1,417.35% | 125.36% |
| Net Income | -1,959.36% | -1,586.61% | -1,327.00% | -838.35% | -17.06% |
| EBIT | 29.77% | 43.60% | 54.58% | 56.86% | 58.06% |
| EBITDA | -179.19% | -517.72% | -- | 83.64% | 96.27% |
| EPS Basic | -362.82% | -149.22% | -70.58% | -1.33% | 64.83% |
| Normalized Basic EPS | 88.85% | 93.54% | 95.41% | 90.40% | 89.01% |
| EPS Diluted | -310.48% | -134.97% | -64.59% | 0.90% | 62.37% |
| Normalized Diluted EPS | 88.85% | 93.54% | 95.41% | 90.40% | 89.01% |
| Average Basic Shares Outstanding | 204.20% | 275.20% | 504.37% | 524.44% | 565.83% |
| Average Diluted Shares Outstanding | 204.20% | 275.21% | 504.37% | 524.44% | 565.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |